我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
隶属于 mubadala healthcare
相关临床试验
68
19 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
16
23.5%
已完成
44
64.7%
Enrolling By Invitation
2
2.9%
尚未招募
1
1.5%
招募中
暂停
Unknown
3
4.4%
暂无批准数据
- A groundbreaking multicenter randomized controlled trial, the LiGHT study, investigates laser treatment effectiveness for glaucoma and ocular hypertension management. - The trial, funded by the National Institute of Health Research Health Technology Assessment Panel, aims to establish new treatment protocols for ocular conditions. - Led by chief investigator GG, the study brings together multiple research centers to evaluate laser intervention outcomes in ophthalmology.